Cargando…
Cortical Excitability Measures May Predict Clinical Response to Fampridine in Patients with Multiple Sclerosis and Gait Impairment
Background: Most multiple sclerosis (MS) patients will develop walking limitations during the disease. Sustained-release oral fampridine is the only approved drug that will improve gait in a subset of MS patients. Objectives: (1) Evaluate fampridine cortical excitability effect in MS patients with g...
Autores principales: | Ahdab, Rechdi, Shatila, Madiha M., Shatila, Abed Rahman, Khazen, George, Freiha, Joumana, Salem, Maher, Makhoul, Karim, El Nawar, Rody, El Nemr, Shaza, Ayache, Samar S., Riachi, Naji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956091/ https://www.ncbi.nlm.nih.gov/pubmed/31817319 http://dx.doi.org/10.3390/brainsci9120357 |
Ejemplares similares
-
Paroxysmal Symptoms in Multiple Sclerosis—A Review of the Literature
por: Freiha, Joumana, et al.
Publicado: (2020) -
Autoimmune Brainstem Encephalitis: An Illustrative Case and a Review of the Literature
por: Zoghaib, Romy, et al.
Publicado: (2021) -
Tremor in Multiple Sclerosis—An Overview and Future Perspectives
por: Makhoul, Karim, et al.
Publicado: (2020) -
Cathodal Transcranial Direct Current Stimulation of the Occipital cortex in Episodic Migraine: A Randomized Sham-Controlled Crossover Study
por: Ahdab, Rechdi, et al.
Publicado: (2019) -
Effects of Transcranial Direct Current Stimulation on Hand Dexterity in Multiple Sclerosis: A Design for a Randomized Controlled Trial
por: Ayache, Samar S., et al.
Publicado: (2020)